Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Virus Research|November 9, 2020
Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfectionRobert L Kruse, Xavier Legras, Mercedes BarziMolecular Therapy. Methods & Clinical Development|October 12, 2017
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV ImmunotherapyRobert L Kruse, Thomas Shum, Xavier Legras, et al.Plos One|May 26, 2017
Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cellsAaron J Velasquez-Mao, Christopher J M Tsao, Madeline N Monroe, et al.Nature Communications|October 19, 2017
Erratum: A novel humanized mouse lacking murine p450 oxidoreductase for studying human drug metabolismMercedes Barzi, Francis P Pankowicz, Barry Zorman, et al.Cell|May 4, 2010
NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathwaysJun Cui, Liang Zhu, Xiaojun Xia, et al.JHEP Reports : Innovation in Hepatology|March 18, 2021
A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genomeRobert L Kruse, Mercedes Barzi, Xavier Legras, et al.Nature Communications|June 30, 2017
A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolismMercedes Barzi, Francis P Pankowicz, Barry Zorman, et al.Cytotherapy|April 11, 2018
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric miceRobert L Kruse, Thomas Shum, Haruko Tashiro, et al.Plos One|October 3, 2012
Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapySatoko Matsueda, Mingjun Wang, Jinsheng Weng, et al.Nature Communications|August 31, 2016
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemiaFrancis P Pankowicz, Mercedes Barzi, Xavier Legras, et al.Pageof 2